Form 4: BIO-key International CEO Michael DePasquale Reports Stock Acquisition

Michael DePasquale, CEO of BIO-key International, reports acquiring 139 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• On December 31, 2024, Michael DePasquale, CEO of BIO-key International, acquired 139 shares of common stock at a price of $1.4 per share.
• The acquisition was made through the BIO-key International, Inc. 2021 Employee Stock Purchase Plan.
• Following the transaction, DePasquale directly owns 39,519 shares of BIO-key International.
• All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.
• Holdings do not include options to purchase 464 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock acquisition by the CEO through an employee stock purchase plan. It doesn't indicate any significant positive or negative development.

Positives

• The CEO's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's prospects. Purchases by executives are often seen as a positive signal.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the CEO's increased investment in the company.

Key Dates

Keywords

BIO-key International, Michael DePasquale, stock acquisition, Employee Stock Purchase Plan, Form 4, BKYI, insider trading